Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 133 of 155
-
Citation: Arthritis Res Ther 2003 5(Suppl 3):150
-
Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts
Citation: Arthritis Res Ther 2003 5(Suppl 3):146 -
Synoviolin as a novel pathogenic factor for arthropathy
Citation: Arthritis Res Ther 2003 5(Suppl 3):144 -
The impact of exogenous and endogenous nucleic acids on the development of joint inflammation
Citation: Arthritis Res Ther 2003 5(Suppl 3):111 -
C5a controls the FcγR activation in inflammatory processes
Citation: Arthritis Res Ther 2003 5(Suppl 3):109 -
Antigen-specific suppression of inflammatory arthritis by dendritic cells
Citation: Arthritis Res Ther 2003 5(Suppl 3):107 -
Immunosuppressive effect of mesenchymal stem cells in collagen-induced arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):105 -
Sox9 represses gene expression via histone deacetylase activity
Citation: Arthritis Res Ther 2003 5(Suppl 3):79 -
Functional haplotypes in citrullinating enzyme peptidylarginine deiminase 4 are associated with rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):75 -
Unbalanced levels of bone resorption promoting factors in bone marrow from patients with rheumatoid arthritis in comparison to osteoarthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):73 -
Activation of synovial fibroblasts via Toll-like receptor signaling
Citation: Arthritis Res Ther 2003 5(Suppl 3):40 -
Variability of pro-apoptotic properties of cyclooxygenase-2 inhibitors in rheumatoid synovial fibroblasts and cancer cell lines
Citation: Arthritis Res Ther 2003 5(Suppl 3):38 -
The role of mPGES-1 for prostaglandin E2 production in primary human synovial cells
Citation: Arthritis Res Ther 2003 5(Suppl 3):36 -
Delineating biologic pathways involved in skeletal growth and homeostasis through the study of rare Mendelian diseases that affect bones and joints
Citation: Arthritis Res Ther 2003 5(Suppl 3):5 -
Streptococcal antigen in the pathogenesis of Behçet's disease
Citation: Arthritis Res Ther 2003 5(Suppl 2):13 -
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model
Citation: Arthritis Res Ther 2003 5(Suppl 2):12 -
Regulation of inflammatory CD28- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
Citation: Arthritis Res Ther 2003 5(Suppl 2):11 -
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease
Citation: Arthritis Res Ther 2003 5(Suppl 2):10 -
Migration of dendritic cells into the lymphatics: the Langerhans cell example
Citation: Arthritis Res Ther 2003 5(Suppl 2):9 -
Behçet's disease: from innate to adaptive immunity
Citation: Arthritis Res Ther 2003 5(Suppl 2):8 -
A review on disease activity scores in Behçet's disease (BD)
Citation: Arthritis Res Ther 2003 5(Suppl 2):7 -
TNF and anti-TNF agents in Behçet's disease
Citation: Arthritis Res Ther 2003 5(Suppl 2):6 -
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
Citation: Arthritis Res Ther 2003 5(Suppl 2):5 -
The use of interferon-alfa in Behçet's disease: review of the literature
Citation: Arthritis Res Ther 2003 5(Suppl 2):4 -
Cytotoxic drugs in ocular lesions of Behçet's disease
Citation: Arthritis Res Ther 2003 5(Suppl 2):3 -
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
Citation: Arthritis Res Ther 2003 5(Suppl 2):2 -
Introduction
Citation: Arthritis Res Ther 2003 5(Suppl 2):1 -
HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia
Genetic control of immune reactions has a major role in the development of rheumatic heart disease (RHD) and differs between patients with rheumatic fever (RF). Some authors think the risk of acquiring RHD is ...
Citation: Arthritis Res Ther 2003 5:R340 -
Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis
Fragments of fibronectin (FN) corresponding to the N-terminal heparin-binding domain have been observed to promote catabolic chondrocytic gene expression and chondrolysis. We therefore characterized FN species...
Citation: Arthritis Res Ther 2003 5:R329 -
Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: implications for rheumatoid arthritis
Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its p...
Citation: Arthritis Res Ther 2003 5:R317 -
Interpreting interest in interferon-α
Citation: Arthritis Res Ther 2003 5:246 -
The role of osteoprotegerin in arthritis
Bone erosion is a hallmark of rheumatoid arthritis. Recent evidence from experimental arthritis suggests that osteoclasts are essential for the formation of local bone erosions. Two essential regulators of ost...
Citation: Arthritis Res Ther 2003 5:239 -
Current state of cartilage tissue engineering
Damage to cartilage is of great clinical consequence given the tissue's limited intrinsic potential for healing. Current treatments for cartilage repair are less than satisfactory, and rarely restore full func...
Citation: Arthritis Res Ther 2003 5:235 -
Ageing, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity – catalysts of autoimmunity and chronic inflammation
Rheumatoid arthritis (RA), like many other autoimmune syndromes, is a disease of adults, with the highest incidence rates reported in the elderly. The immune system undergoes profound changes with advancing ag...
Citation: Arthritis Res Ther 2003 5:225 -
Ageing, autoimmunity and arthritis: An introduction
Citation: Arthritis Res Ther 2003 5:223 -
Mactinin: a modulator of the monocyte response to inflammation
During inflammatory processes, monocytes leave the blood stream at increased rates and enter inflammation tissue, where they undergo phenotypic transformation to mature macrophages with enhanced phagocytic act...
Citation: Arthritis Res Ther 2003 5:R310 -
A review of anabolic therapies for osteoporosis
Osteoporosis results from a loss of bone mass and bone structure such that the bone becomes weak and fractures with very little trauma. Until recently, the approved osteoporosis therapies prevented more bone l...
Citation: Arthritis Res Ther 2003 5:214 -
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer
Anakinra, the recombinant form of IL-1 receptor antagonist (IL-1Ra), has been approved for clinical use in the treatment of rheumatoid arthritis as the drug Kineretâ„¢, but it must be administered daily by subcu...
Citation: Arthritis Res Ther 2003 5:R301 -
Articles selected from Faculty of 1000 in July 2003
Citation: Arthritis Res Ther 2003 5:E2 -
Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis
Circulating CD3+CD4+CD28- cells exhibit reduced apoptosis and were found to be more enriched in patients with ankylosing spondylitis than in age-matched healthy control individuals (7.40 ± 6.6% versus 1.03 ± 1.0%...
Citation: Arthritis Res Ther 2003 5:R292 -
The value of sensitive imaging modalities in rheumatoid arthritis
X-ray evaluation of rheumatoid joints is relatively inexpensive, is widely available and has standardised methods for interpretation. It also has limitations, including the inability to reliably determine stru...
Citation: Arthritis Res Ther 2003 5:210 -
The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes
A synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO), has been reported to have anti-inflammatory properties and to decrease the interleukin-1 (IL-1)-induced expression of matrix metal...
Citation: Arthritis Res Ther 2003 5:R285 -
An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis
The aim of this research was to determine whether all memory T cells have the same propensity to migrate to the joint in patients with juvenile idiopathic arthritis. Paired synovial fluid and peripheral blood ...
Citation: Arthritis Res Ther 2003 5:R277 -
Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients
An impaired differentiation of naive CD4+ T cells towards Th2 cells may contribute to the chronic tissue-destructive T-cell activity in rheumatoid arthritis (RA). The differentiation of naive CD4+ T cells into me...
Citation: Arthritis Res Ther 2003 5:R269 -
Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease - evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β1 expression in active disease
Behçet's disease is a multisystem disease in which there is evidence of immunological dysregulation. It has been proposed that γ/δ T cells are involved in its pathogenesis. The aim of the present study was to ...
Citation: Arthritis Res Ther 2003 5:R262 -
Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-α in periarticular tenocytes from patients with knee joint osteoarthritis
The aim of the present study was to investigate the expression of Fas in periarticular tenocytes of patients with osteoarthritis (OA) and to study their susceptibility to Fas ligand-mediated apoptosis. Tendon ...
Citation: Arthritis Res Ther 2003 5:R253 -
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis
To improve our knowledge on the pathophysiology of rheumatoid arthritis (RA), we investigated gene expression patterns in synovial tissue from RA and osteoarthritis (OA) patients. DNA oligonucleotide microarra...
Citation: Arthritis Res Ther 2003 5:R241 -
SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus
Hematopoietic stem cell transplantation was first reported for patients with systemic lupus erythematosus in 1997. The procedure has since been performed worldwide including in Europe, in Brazil, and in China....
Citation: Arthritis Res Ther 2003 5:207 -
Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis
We investigated whether plasma and synovial fluid (SF) samples from patients with rheumatoid arthritis (RA) contained extracellular mitochondrial DNA (mtDNA) or the oxidatively damaged DNA adduct 8-hydroxy-2'-...
Citation: Arthritis Res Ther 2003 5:R234 -
Put your heart into the joint benefits of statins!
Citation: Arthritis Res Ther 2003 5:202